Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease

International Journal of Molecular Sciences

Wenna Guo¹  Fangxia Guan¹  Shanshan Ma¹  Linyan Duan¹  Yifu Wang¹  Xingfan Li¹  Qianqian Wang¹ 

[1] School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China;

关键词: glucose metabolism;    neural cell senescence;    Alzheimer’s disease;    metabolic reprogramming;    therapeutics;   

DOI  :  10.3390/ijms23084351

来源: DOAJ

【 摘 要 】

Alzheimer’s disease (AD), an elderly neurodegenerative disorder with a high incidence and progressive memory decline, is one of the most expensive, lethal, and burdening diseases. To date, the pathogenesis of AD has not been fully illustrated. Emerging studies have revealed that cellular senescence and abnormal glucose metabolism in the brain are the early hallmarks of AD. Moreover, cellular senescence and glucose metabolism disturbance in the brain of AD patients may precede amyloid-β deposition or Tau protein phosphorylation. Thus, metabolic reprogramming targeting senescent microglia and astrocytes may be a novel strategy for AD intervention and treatment. Here, we recapitulate the relationships between neural cell senescence and abnormal glucose metabolism (e.g., insulin signaling, glucose and lactate metabolism) in AD. We then discuss the potential perspective of metabolic reprogramming towards an AD intervention, providing a theoretical basis for the further exploration of the pathogenesis of and therapeutic approach toward AD.

【 授权许可】

Unknown